Angioflux

Active substance

Sulodexide

Strenght and pharmaceutical forms

250 LRU Soft capsules - 50 capsules
600 LRU/2ml injectable solution – 10 vials

ATC

B01AB11 -Anti-thrombotic/Heparinic

Therapeutic Indications

Chronic venous ulcers

Marketing Authorization Holder

Aesculapius Farmaceutici S.r.l.

Download area

Summary of Product Characteristics - Angioflux